Hemab ApS (Denmark)

Homepage: hemab.com

Alternate names: Hemab, Hemab ApS, Hemab Therapeutics, Hemab Therapeutics Holdings, Inc.

ROR: 05dqjxj38

OpenAlex ID: I4405268022

A bispecific antibody approach for the potential prophylactic treatment of inherited bleeding disorders

2024 · Prafull S. Gandhi, Minka Zivkovic, et al. · Nature Cardiovascular Research · 22

Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for ultra-rare inherited bleeding disorders

2023 · Diane Nugent, Suchitra S. Acharya, et al. · Expert Review of Hematology · 21

HMB-002: a monovalent antibody that elevates circulating VWF and FVIII levels for treatment of von Willebrand disease

2026 · Mattias Häger, Minka Zivkovic, et al. · Blood Advances · 4

A Phase 1/2, First-in-Human, Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Participants with Glanzmann Thrombasthenia

2023 · Suthesh Sivapalaratnam, Steve Austin, et al. · Blood · 3

A Prospective, Observational Study of Bleeding and Quality of Life in Patients with Glanzmann Thrombasthenia in the United Kingdom: Updated Results

2023 · Catherine Rea, Thomas York, et al. · Blood · 1

Overview of dose-finding designs and trials in cell and gene therapies

2026 · Revathi Ananthakrishnan, Bambang Adiwijaya, et al. · Journal of Biopharmaceutical Statistics

Pivotal trial design considerations for new and next generation cell and gene therapies

2026 · Patricia Anderson, Zhenzhen Xu, et al. · Journal of Biopharmaceutical Statistics

Validation approach of an LC-MS/MS assay for ADA detection, applied to a Von Willebrand factor-targeted biotherapeutic

2026 · Frank B. Schalk, Kayla Shumate, et al. · Bioanalysis

A Phase 1/2 Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Participants with Glanzmann Thrombasthenia

2024 · Suthesh Sivapalaratnam, Steve Austin, et al. · Blood

Athn Transcends Natural History Cohort Study of Bleeding Symptoms and Treatment Outcomes in Patients with Glanzmann Thrombasthenia

2023 · Tammuella Chrisentery-Singleton, Carrie O'Neill, et al. · Blood

Works count: 10

Citation count: 214